U.S. Dialysis Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
U.S. Dialysis Market size was valued at around USD 28.8 billion in 2023 and is expected to exhibit growth at a CAGR of 5.5% from 2024 to 2032. High market growth can be attributed to the rising number of end-stage renal diseases (ESRD) patients and increasing incidence of diabetes among other contributing factors.
The growing prevalence of ESRD is a major driver of expansion in the U.S. dialysis market. ESRD, the final stage of chronic kidney disease (CKD), requires either regular dialysis or a kidney transplant for survival, leading to a heightened demand for dialysis services and equipment. This increase in ESRD cases is largely attributed to the rising incidence of chronic conditions such as diabetes and hypertension, which are primary contributors to kidney damage. Additionally, the aging U.S. population, which experiences a natural decline in kidney function with age, further accelerates the demand for dialysis services among older adults.
For instance, according to the U.S. Renal Data System (USRDS) report 2020, there were approximately 808,000 people in the U.S. living with ESRD, with nearly 70% undergoing dialysis treatment. Additionally, the CDC reports that diabetes and hypertension are responsible for 38% and 26% of new ESRD cases, respectively. This rising prevalence of ESRD drives the expansion of the market, as it aims to address the growing needs of this increasing patient population.
Dialysis is a medical procedure that artificially performs the functions of the kidneys by removing waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to do so effectively due to kidney failure or chronic kidney disease. Dialysis helps maintain a balance of fluids, electrolytes, and waste in the body, crucial for patients with severe kidney dysfunction.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
U.S. Dialysis Market size in 2023: | USD 28.8 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 5.5 |
2023 Value Projection: | USD 45.5 Billion |
Historical Data for: | 2021 - 2023 |
No of Pages: | 100 |
Tables, Charts & Figures: | 397 |
Segments Covered: | Type, Product and Services, End-use, and Zone |
Growth Drivers: |
|
Pitfalls Challenges: |
|
The favourable reimbursement scenario for dialysis treatment is a key factor driving the growth of the market. Government programs such as Medicare provide extensive coverage for dialysis treatment, making it more accessible to patients with ESRD.
Based on type, the market is categorized into hemodialysis and peritoneal dialysis. The hemodialysis segment dominated the market with a revenue of around USD 25.4 billion in 2023.
Based on product and services, the U.S. dialysis market is categorized into services, consumables, and equipment. The service segment dominated the market in 2023 with a market share of around 78.3%.
Based on end-use, the U.S. dialysis market is categorized into in-center dialysis and home dialysis. The in-center dialysis segment dominated the market in 2023 and is anticipated to reach USD 38.3 billion by the end of forecast period.
The South Atlantic dialysis market accounted for USD 6.5 billion market revenue in 2023 and is anticipated to grow at CAGR of 5.1% between 2024 – 2032 period.
Northeast dialysis market is projected to grow remarkably in the coming years.
The market is characterized by a competitive landscape with numerous national and regional players vying for market share. Major key players are offering advanced products and standardized services contributing to the market expansion. Regional providers are also expanding their services to capture local market segments. Competition drives innovation, improving patient care and operational efficiency. Strategic partnerships, acquisitions, and technological advancements further enhance the competitive dynamics in the market.
Some of the eminent market participants operating in the U.S. dialysis industry include:
Market, By Type
Market, By Product and Services
Market, By End-use
The above information is provided for the following zones:
U.S. dialysis industry was valued at USD 28.8 billion in 2023 and is expected to exhibit 5.5% CAGR from 2024 to 2032 attributed to the rising number of end-stage renal diseases (ESRD) patients and increasing incidence of diabetes
The hemodialysis type segment in the market recorded USD 25.4 billion in 2023 as it is the standard treatment for the majority of patients with ESRD, particularly those who may not be candidates for home-based therapies.
Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, DaVita Inc., Fresenius Medical Care AG & Co., Innovative Renal Care., Medtronic plc, Nikkiso Co., Ltd., Nipro Corporation, Toray Industries Inc., and U.S. Renal Care, Inc.
South Atlantic U.S. dialysis industry size is anticipated to grow at 5.1% CAGR between 2024 and 2032 led by rapidly aging population in Florida, Georgia, and North and South Carolina